What does DR. KATELIJNE VERBEKE - ANESTHESIST do?

DR. KATELIJNE VERBEKE - ANESTHESIST is a specialist medical practice in Gent. Private Limited, started on 18 February 2016, 1 establishment.

What is the address of DR. KATELIJNE VERBEKE - ANESTHESIST?

The registered office of DR. KATELIJNE VERBEKE - ANESTHESIST is located at Witbakkerstraat 26, 9051 Gent.

Is DR. KATELIJNE VERBEKE - ANESTHESIST still active?

Yes. According to the CBE (31 October 2026) DR. KATELIJNE VERBEKE - ANESTHESIST is active, legal situation “Normale toestand”, started on 18 February 2016.

Is DR. KATELIJNE VERBEKE - ANESTHESIST registered on Peppol?

Yes, DR. KATELIJNE VERBEKE - ANESTHESIST is registered on the Peppol network with ID 0208:0648898722.

What is the enterprise number of DR. KATELIJNE VERBEKE - ANESTHESIST?

The enterprise number of DR. KATELIJNE VERBEKE - ANESTHESIST is BE0648898722.

When was DR. KATELIJNE VERBEKE - ANESTHESIST founded?

DR. KATELIJNE VERBEKE - ANESTHESIST was founded on 18 February 2016.

Who are the directors of DR. KATELIJNE VERBEKE - ANESTHESIST?

According to the 2025 annual accounts, the directors of DR. KATELIJNE VERBEKE - ANESTHESIST are: Katelijne Verbeke.

Is DR. KATELIJNE VERBEKE - ANESTHESIST a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 February 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. KATELIJNE VERBEKE - ANESTHESIST make in 2025?

DR. KATELIJNE VERBEKE - ANESTHESIST posted a profit after taxes of € 190,738 in financial year 2025.

What is the revenue of DR. KATELIJNE VERBEKE - ANESTHESIST?

As a small company, DR. KATELIJNE VERBEKE - ANESTHESIST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 293,007.

DR. KATELIJNE VERBEKE - ANESTHESIST (Private Limited)

Dossier DR. KATELIJNE VERBEKE - ANESTHESIST, printed on 31 October 2026 from databakkes.be/en/0648898722/dr-katelijne-verbeke-anesthesist. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. KATELIJNE VERBEKE - ANESTHESIST from Gent, company number BE0648898722, closed financial year 2025 with a result of € 190,738 after tax. For that financial year DR. KATELIJNE VERBEKE - ANESTHESIST recorded a gross margin of € 293,007 and equity of € 211,198. Compared with financial year 2024, the result moved from € 73,913 to € 190,738. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 211,198

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 190,738

▲ 158% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 191,781

▲ 64% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 175,734 paid out

92 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 21,477

▼ 44% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 12,537

▼ 46% vs 2024

€ 10,740 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 2,889

▼ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 31,559

▲ € 28,384 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 139,860 Gross margin 2022: € 139,860 First fiscal year in the series	€ 122,304 Gross margin 2023: € 122,304 ▼ 13% vs 2022 (€ 139,860) Unfavourable step	€ 134,117 Gross margin 2024: € 134,117 ▲ 10% vs 2023 (€ 122,304) Favourable step	€ 293,007 Gross margin 2025: € 293,007 ▲ 118% vs 2024 (€ 134,117) Favourable step	▲ 118%
Profit after taxes	€ 84,739 Profit after taxes 2022: € 84,739 First fiscal year in the series	€ 68,455 Profit after taxes 2023: € 68,455 ▼ 19% vs 2022 (€ 84,739) Unfavourable step	€ 73,913 Profit after taxes 2024: € 73,913 ▲ 8% vs 2023 (€ 68,455) Favourable step	€ 190,738 Profit after taxes 2025: € 190,738 ▲ 158% vs 2024 (€ 73,913) Favourable step	▲ 158%
Equity	€ 238,359 Equity 2022: € 238,359 First fiscal year in the series	€ 263,457 Equity 2023: € 263,457 ▲ 11% vs 2022 (€ 238,359) Favourable step	€ 196,194 Equity 2024: € 196,194 ▼ 26% vs 2023 (€ 263,457) Unfavourable step	€ 211,198 Equity 2025: € 211,198 ▲ 8% vs 2024 (€ 196,194) Favourable step	▲ 8%
Total debts	€ 62,563 Total debts 2022: € 62,563 First fiscal year in the series	€ 40,200 Total debts 2023: € 40,200 ▼ 36% vs 2022 (€ 62,563) Favourable step	€ 32,210 Total debts 2024: € 32,210 ▼ 20% vs 2023 (€ 40,200) Favourable step	€ 49,604 Total debts 2025: € 49,604 ▲ 54% vs 2024 (€ 32,210) Unfavourable step	▲ 54%
Cash	€ 177,935 Cash 2022: € 177,935 First fiscal year in the series	€ 200,776 Cash 2023: € 200,776 ▲ 13% vs 2022 (€ 177,935) Favourable step	€ 116,851 Cash 2024: € 116,851 ▼ 42% vs 2023 (€ 200,776) Unfavourable step	€ 191,781 Cash 2025: € 191,781 ▲ 64% vs 2024 (€ 116,851) Favourable step	▲ 64%
Retained profit	€ 219,759 Retained profit 2022: € 219,759 First fiscal year in the series	€ 244,857 Retained profit 2023: € 244,857 ▲ 11% vs 2022 (€ 219,759) Favourable step	€ 177,594 Retained profit 2024: € 177,594 ▼ 27% vs 2023 (€ 244,857) Unfavourable step	€ 192,598 Retained profit 2025: € 192,598 ▲ 8% vs 2024 (€ 177,594) Favourable step	▲ 8%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 43,357 Dividend 2023: € 43,357 Unchanged (€ 0) Unchanged	€ 141,176 Dividend 2024: € 141,176 ▲ 226% vs 2023 (€ 43,357) Unchanged	€ 175,734 Dividend 2025: € 175,734 ▲ 24% vs 2024 (€ 141,176) Unchanged	▲ 24%
Bank debt	€ 57,164 Bank debt 2022: € 57,164 First fiscal year in the series	€ 33,786 Bank debt 2023: € 33,786 ▼ 41% vs 2022 (€ 57,164) Favourable step	€ 23,200 Bank debt 2024: € 23,200 ▼ 31% vs 2023 (€ 33,786) Favourable step	€ 12,537 Bank debt 2025: € 12,537 ▼ 46% vs 2024 (€ 23,200) Favourable step	▼ 46%
Balance sheet total	€ 300,923 Balance sheet total 2022: € 300,923 First fiscal year in the series	€ 303,657 Balance sheet total 2023: € 303,657 ▲ 1% vs 2022 (€ 300,923) Unchanged	€ 228,404 Balance sheet total 2024: € 228,404 ▼ 25% vs 2023 (€ 303,657) Unchanged	€ 260,802 Balance sheet total 2025: € 260,802 ▲ 14% vs 2024 (€ 228,404) Unchanged	▲ 14%

Key figures of DR. KATELIJNE VERBEKE - ANESTHESIST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. KATELIJNE VERBEKE - ANESTHESIST?

What happened at DR. KATELIJNE VERBEKE - ANESTHESIST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 190,738 (▲ 158% vs 2024). Source: NBB ↗
Feb 23, 2016 New establishment in Gent. KBO
2016 Katelijne Verbeke became a director. NBB
Feb 18, 2016 Start of the company according to the CBE. KBO

In short

From € 84,739 profit in 2022 to € 190,738 profit in 2025.

Paid € 123,371 in corporate taxes since 2022.

Best year ever: 2025, with € 190,738 profit.

Paid out € 360,267 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Katelijne Verbeke

DR. KATELIJNE VERBEKE - ANESTHESIST

Behind DR. KATELIJNE VERBEKE - ANESTHESIST is Katelijne Verbeke.

Directors

According to the 2025 annual accounts

Katelijne Verbeke

Director

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Witbakkerstraat 26

9051 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

LADIVA

Yves J.L. Declercq en Co

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0648.898.722
VAT number: BE 0648.898.722
Registered office: Witbakkerstraat 26, 9051 Gent
Names & denominations: DR. KATELIJNE VERBEKE - ANESTHESIST
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 February 2016
Peppol: Active · Active since 20 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗